xis in anesthesia

50
 ANAPHYLAXI S IN  ANESTHESIA 

Upload: surbhi-mittal

Post on 07-Apr-2018

220 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 1/50

 ANAPHYLAXIS IN

 ANESTHESIA 

Page 2: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 2/50

HISTORY 

The term anaphylaxis was coined by PORTER ANDRICHET in 1902

In greek prophylaxis means “protection”,

 ANAPHYLAXIS means opposite protection Anaphylaxis generally occurs on re-exposure to a

specific antigen and requires the release of proinflammatory mediators but it can also occur on

first exposure because of cross reactivity amongcommercial products and drugs .

Page 3: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 3/50

GELL AND COOMB’S CLASIFICATION

 ANAPHYLAXIS is a TYPE 1 reaction IgE mediatedhypersenstivity reaction

TYPE 2 reactions involve IgG Ig M and complement

mediated cytotoxicity  TYPE 3 REACTIONS involve immune complex

formation and deposition leads to tissue damage

TYPE 4 reactions are delayed type hypersenstivity 

reactions

Page 4: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 4/50

 ANAPHYLACTOID REACTIONS

 ANAPHYLACTOID REACTIONS occur through adirect nonimmune mediated reaction via release of mediators from mast cells and basophils but they present with symptoms similar to those of anaphylaxis

Page 5: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 5/50

SCOPE

Prevalence and incidence

Cause of perioperative anaphylaxis

Diagnosis

Management

Page 6: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 6/50

PREVALENCE

IT IS Difficult to determine incidence and prevalenceof anaphy.

 Acc. To an estimate it is 1 in 3500 to 1 in 13000

Mortality 3-6 % Multiple drugs are administered during anesthesia

 And because patients are under drapes early cutaneous symptoms are often unrecognized

no available diagnostic test with absolute accuracy 

NMBA usually result skin test +ve for long time

Page 7: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 7/50

CLINICAL HISTORY 

1.Extent of sign of anaphylaxis

2. Drugs and related compounds

3. Time elapsed between administration and

onset of symptom 4. Previous allergies from drugs or related

compounds

5. underlying conditions

Page 8: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 8/50

EXTENT OF SIGNS OF ANAPHYLAXIS

In most cases

 perioperative anaphylaxis is

characterized by cardiovascular 

manifestation (73.6%),cutaneous symptoms(69.6%),and bronchospasm (44.2%) of cases. 

Page 9: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 9/50

Time elapsed between administration andonset of symptom

Clinical sign usually start within 5-10 min after IV 

administration but may occur in second

NRL and antiseptics exhibit more delay onset and

generally occur in maintenance anesthesia orrecovery room

Colloid may cause immediate reaction or delay onset

Page 10: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 10/50

4.Previous allergies from drugsor related compound

Careful retrospective assessment of medical

history and record

Identify risk of patients during preanesthetic visit

Page 11: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 11/50

5.Underlying conditions

identified underlying condition can also help

to identify causative compounds

 Atopic individual are at the risk of anaphylaxis

from NRL Mastocytosis,

Page 12: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 12/50

CLINICAL FEATURES

Cutaneous sym.

Flushing ,pruritus urticaria ,angioedema

G.it. Sym.

Nausea ,vomitting ,abdominal cramps ,diarrhoea  Absent or difficult to differentiate in general

anesthesia , may be present in regional anesthesia orM.A.C.

Respiratory sym. rhinitis ,laryngeal edema,shortness of 

 breath,wheezing,respiratory arrest

Page 13: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 13/50

i

Increased peak inspiratory pressure, increased endtidal carbon dioxide ,decreased oxygensaturation,wheezing,bronchospasm

CARDIOVASCULAR SYM.

Tachycardia ,hypotension,cardiac arrythmias ,cardiovascular collapse

RENAL SYM.

Decreased Urine output HEMATOLOGIC SYM.

D.I.C.

Page 14: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 14/50

PATHOPHYSIOLOGY 

On initial exposure IgE is produced and binds tomast cells and basophils

On reexposore multimeric antigen cross links two

IgE receptors initiating a signal transduction cascade  Which culminates in increase of calcium and release

of mediators such ashistamine,proteases,proteoglycans,and P.A.F.

Page 15: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 15/50

TRYPTASE

Neutral serine proteinase

Mature -tryptase reflect mast cell activation

Pro -tryptase reflect mast cell number

Mast cell or basophil 60-120 min collection after event

Compare 2 sample in the same person

Persistent elevate in…..  False – ve & false

Page 16: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 16/50

ETIOLOGY 

NMBAs – 69.2% succinyl choline ,rocuronium,atra.

NRL- 12.1% latex gloves

 Antibiotics-8% penicillin,and beta lactams

Colloid- 3.7% dextran,gelatin Hypnotics-2.7% propofol,thiopentone

Opioids- 1.4% morphine ,meperidine

Local anesthetic agent- Miscellaneous -aprotinin,chymopapain,protamine,

Page 17: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 17/50

TREATMENT

DISCONTINUATIN OF DRUG OR ANESTHETIC

100% OXYGEN AIRWAY SUPPORT to incraseoxygen delivery and maintain airway 

IV FLUIDS (2-4litres) for compensation of systemic vasodilation.

EPINEPHRINE is drug of choice because its alpha 1effects support the blood pressure and beta 2 effectsprovide bronchial smooth muscle relaxation

5-10micrograms initial bolus upto 100-500mic. For vascular collapse , start drip with 1 mic./min. forrefractory hypotension

Page 18: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 18/50

CONTINUED…. 

H1 blockers diphenhydramine 25-50 mg should beused early but their role is controversial once cardiacsym. Set in

H2 blockers ranitidine 150 ms bolus or cim etdine

400mg bolus should be added Bronchodilators eg.albuterol and ipratropium

 bromide nebulizers

Corticosteroids decrease airway swelling andprevent recurrence of sym.as seen in protracted and

 biphasic ana.hydrocortisone is preferred steroid because of fast onset

Page 19: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 19/50

CONTINUED…….. 

Extubation should be delayed .because airway swelling and inflamation may continue for 24 hours. Patient should be managed in I.C.U.

Page 20: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 20/50

PREVENTION

Page 21: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 21/50

MUSCLE RELAXANTS

NMBAs are most common cause of anaphylaxis Short acting depolarizing is at greatest risk 

succinylcholine because it contains a flexiblemolecule that crossreacts link 2 mast cell IgEreceptors and induce mast celldegranulation

N.M.B. Induce 2 type of reactions

- IgE dependent => NH4+ main antigenic epitope - direct mast cell activation => benzylisoquinolinium

cisatracurium has lowest risk of mast cell activation

Page 22: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 22/50

Data controversy in rocuronium

Cross reactivity between NMBAs is 65% by skin test

and 80% by RIA 

Pattern of cross reactivity vary between personCross reactivity depend on configuration,

flexibility,inter-ammonium distant

Unusual to allergic to all NMBAs But keep in mind some pt. might suffer from

multiple allergies

Page 23: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 23/50

PREVENTION

 Avoid NMBAs for patient with previoushistory to reation in future

anesthesia whenever possible 

Page 24: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 24/50

LOCAL ANASTHETICS

vasovagal responses ,tachycardia,lighthededness orMetallic taste , perioral numbness can result fromintravascular injection of local anesthetic orepinephrine

 Anaphylaxis is very rare, type 4 reaction is mostcommon

 Amide-rare , ester< 1% for anaphylaxis

Ester metabolite=> PABA usually cause

type I reaction

Preservative => methylparaben

Page 25: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 25/50

HYPNOTICS

Cross reactivity between thiopental sodium

 barbitone,methohexital( rare anaphylaxis)

Propofol => alkyl phenol that bear 2 isopropyl

groups that act as antigenic epitopes - cross react with eggs ,soy and lechitins in

propofol vehicle ?

upto now no evidence support this postulate

Page 26: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 26/50

OPOIDS

generalized reaction to opioids usually result

from nonspecific mast cell activation

Skin mast cell are sensitive to nonspecific

activation , in contrast to heart,GI,lung How about basophil?

Classification of opioid

- phenanthrene (morphine,codeine) - phenylpiperedine(phentanyl,meperidine)

- diphenylheptane(methadone,propoxyphene

Page 27: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 27/50

Most of reaction are not life-treatening reaction

Fentanyl appear not to activate mast cell

Data in cross reactivity of opioid subclass is

inconclusive SPT for opioids is not useful Placebo controlled

challenges may be required to

diagnose opioid allergy 

Page 28: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 28/50

NATURAL RUBBER 

Divided into 2 groups

- atopic

- significant exposure=>HCP, Neural tube

defect 20% of perioperative anaphylaxis

Use questionaire

Rx => avoidance

Page 29: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 29/50

% of perioperative anaphylaxis

20% severe reaction

20 min after administration

Gelatin allergy  - Skin test (phadiac 74,BAT

HES

- skin test

Page 30: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 30/50

rextran => DIAR 

- IgG immune complex dis

- prevent by hapten dextran (1Kd) infusion

- skin test is not established  Albumin anaphylaxis is anectodal case

Page 31: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 31/50

Chlorhexidine and other antiseptics

Cationic biguanide

Chlorhexidine salt can trigger irritant

dermatitis

SPT 10 fold dilution of chlorhexidine digluconate in 70% alcohol

sIgE (c8,Phadia)

Povidone iodine => anaphylaxis is rare

Page 32: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 32/50

OTHER AGENTS

Hyaluronidase

Oxytocin

dyes

 Aprotinin Protamine and heparin

Page 33: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 33/50

PROTAMINE

Isolate from the sperm of fish

 Antidote for heparin

Significant histamine release

Previous exposure (NPH),heparin neutralization, vasectomy,fish allergy may 

risk for anaphylaxis

But these finding not confirm Skin test ,sIgE may be helpful

Page 34: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 34/50

 

Page 35: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 35/50

 

cardiac

Page 36: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 36/50

cardiaccatheterization 

Page 37: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 37/50

conclusion

Prevance of peri-operative anaphylaxis

Diagnostic approach

NMBAs is MCM cause

Diagnostic test  Anaphylaxis and anaphylactoid

 Almost procedure and medication can cause

peri-operative anaphylaxis

Page 38: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 38/50

 

Page 39: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 39/50

 

Page 40: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 40/50

 

Page 41: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 41/50

 

Page 42: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 42/50

 

Page 43: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 43/50

 

Page 44: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 44/50

 

Page 45: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 45/50

 

Page 46: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 46/50

 

Page 47: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 47/50

 

Page 48: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 48/50

 

Page 49: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 49/50

 

Page 50: xis in Anesthesia

8/4/2019 xis in Anesthesia

http://slidepdf.com/reader/full/xis-in-anesthesia 50/50